UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Associations between fruit consumption and home blood pressure in a randomly selected sample of the general Swedish population

The journal of clinical hypertension (Greenwich, Conn.), 2022-06, Vol.24 (6), p.723-730

2022

Volltextzugriff (PDF)

NT-proBNP by Itself Predicts Death and Cardiovascular Events in High-Risk Patients With Type 2 Diabetes Mellitus

Journal of the American Heart Association, 2020-10, Vol.9 (19), p.e017462-e017462

2020

Volltextzugriff (PDF)

Effects of sacubitril/valsartan on glycemia in patients with diabetes and heart failure: the PARAGON-HF and PARADIGM-HF trials

Cardiovascular diabetology, 2022-06, Vol.21 (1), p.1-11, Article 110

2022

Volltextzugriff (PDF)

Resistance to antihypertensive treatment and long‐term risk: The Atherosclerosis Risk in Communities study

The journal of clinical hypertension (Greenwich, Conn.), 2021-10, Vol.23 (10), p.1887-1896

2021

Volltextzugriff (PDF)

Blood pressure and mortality in patients with type 2 diabetes and a recent coronary event in the ELIXA trial

Cardiovascular diabetology, 2020-10, Vol.19 (1), p.175-175, Article 175

2020

Volltextzugriff (PDF)

Angiotensin Receptor Neprilysin Inhibition: An Overlooked Frontier in the Treatment of Hypertension

JACC. Asia, 2024-09, Vol.4 (9), p.708-709

Wijkman, Magnus O.

2024

Volltextzugriff (PDF)

Dissatisfaction with teeth in type 2 diabetes is associated with increased risk of cardiovascular disease

Diabetes epidemiology and management, 2022-10, Vol.8, p.100090, Article 100090

2022

Volltextzugriff (PDF)

Sacubitril–valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction

European heart journal, 2021-09, Vol.42 (36), p.3741-3752

2021

Volltextzugriff (PDF)

Cardiac Structure and Function Across the Spectrum of Aldosteronism: the Atherosclerosis Risk in Communities Study

Hypertension (Dallas, Tex. 1979), 2022-09, Vol.79 (9), p.1984-1993

2022

Volltextzugriff (PDF)

1089-P: Importance of Cardiorenal Complications for Prognosis in Persons with Type 1 Diabetes and Controls

Diabetes (New York, N.Y.), 2022-06, Vol.71 (Supplement_1)

2022

Volltextzugriff (PDF)

Beta‐blockers, hypertension, and stroke outcomes

The journal of clinical hypertension (Greenwich, Conn.), 2018-03, Vol.20 (3), p.573-574

Wijkman, Magnus O.

2018

Volltextzugriff (PDF)

Importance of NT-proBNP and conventional risk factors for prediction of death in older adults with and without diabetes mellitus- A report from the Atherosclerosis Risk in Communities (ARIC) study

Diabetes research and clinical practice, 2022-12, Vol.194, p.110164-110164, Article 110164

2022

Volltextzugriff (PDF)

Effect of liraglutide on markers of insulin production in persons with type 2 diabetes treated with multiple daily insulin injections

Journal of diabetes and its complications, 2022-03, Vol.36 (3), p.108110-108110, Article 108110

2022

Volltextzugriff (PDF)

The exaggerated blood pressure response to exercise in the sub‐acute phase after stroke is not affected by aerobic exercise

The journal of clinical hypertension (Greenwich, Conn.), 2018-01, Vol.20 (1), p.56-64

2018

Volltextzugriff (PDF)

64-OR: Sustained Intensive Treatment and Long-Term Effects on A1C Reduction (SILVER Study) by CGM in Persons with T1D Treated with MDI

Diabetes (New York, N.Y.), 2020-06, Vol.69 (Supplement_1)

2020

Volltextzugriff (PDF)

NT-proBNP versus routine clinical risk factors as a predictor of cardiovascular events or death in people with dysglycemia – A brief report from the ORIGIN trial

Journal of diabetes and its complications, 2021-07, Vol.35 (7), p.107928-107928, Article 107928

2021

Volltextzugriff (PDF)

Predictors and correlates of systolic blood pressure reduction with liraglutide treatment in patients with type 2 diabetes

The journal of clinical hypertension (Greenwich, Conn.), 2019-01, Vol.21 (1), p.105-115

2019

Volltextzugriff (PDF)

2-OR: Impact of N Terminal Pro B-Type Natriuretic Peptide and High Sensitivity Cardiac Troponin on the Prediction of Death and Cardiovascular Events in High-Risk Patients with Type 2 Diabetes

Diabetes (New York, N.Y.), 2020-06, Vol.69 (Supplement_1)

2020

Volltextzugriff (PDF)

Angiotensin Receptor Neprilysin Inhibition

JACC. Asia, 2024-09, Vol.4 (9), p.708-709

Wijkman, Magnus O.

2024

Volltextzugriff (PDF)

HIGHER PREVALENCE OF MASKED UNCONTROLLED HYPERTENSION WITH NEW EUROPEAN BLOOD PRESSURE TARGETS IN AN ELDERLY PRIMARY CARE POPULATION

Journal of hypertension, 2022-06, Vol.40 (Suppl 1), p.e316-e317

2022

Volltextzugriff (PDF)

Discordance between mean glucose and time in range in relation to HbA 1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials

Diabetologia, 2024, Vol.67 (8), p.1517

2024

Volltextzugriff (PDF)

Evaluation of Effects of Continuous Glucose Monitoring on Physical Activity Habits and Blood Lipid Levels in Persons With Type 1 Diabetes Managed With MDI: An Analysis Based on the GOLD Randomized Trial (GOLD 8)

Journal of diabetes science and technology, 2024, Vol.18 (1), p.89

2024

Volltextzugriff (PDF)

Treatment Satisfaction and Well-Being With CGM in People With T1D: An Analysis Based on the GOLD Randomized Trial

Journal of diabetes science and technology, 2023, Vol.In Press, p.19322968231183974-19322968231183974

2023

Volltextzugriff (PDF)

Abstract 14482: Apparent Resistant Hypertension is a Marker of Risk: The Atherosclerosis Risk in Communities (ARIC) Study

Circulation (New York, N.Y.), 2020-11, Vol.142 (Suppl_3 Suppl 3), p.A14482-A14482

2020

Volltextzugriff (PDF)

1421-P: The Impact of Blood Pressure on Risk of Death Is Influenced by Prior Cardiovascular Disease in Patients with Type 2 Diabetes and a Recent Coronary Event

Diabetes (New York, N.Y.), 2020-06, Vol.69 (Supplement_1)

2020

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(27)

Sprache

Englisch
(27)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(16)
Science & Technology
(16)
Humans
(14)
Diabetes
(11)
Cardiovascular System & Cardiology
(10)
Diabetes Mellitus
(8)
Endocrinology & Metabolism
(8)
Heart Failure
(7)
Female
(6)
Hypertension
(6)
Male
(6)
Middle Aged
(6)
Mortality
(6)
Peripheral Vascular Disease
(6)
Aged
(5)
Blood Pressure
(5)
Risk Factors
(5)
Diabetes Mellitus, Type 2 - Drug Therapy
(4)
Endocrinology And Diabetes
(4)
Endokrinologi Och Diabetes
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Associations between fruit consumption and home blood pressure in a randomly selected sample of the general Swedish population

NT-proBNP by Itself Predicts Death and Cardiovascular Events in High-Risk Patients With Type 2 Diabetes Mellitus

Effects of sacubitril/valsartan on glycemia in patients with diabetes and heart failure: the PARAGON-HF and PARADIGM-HF trials

Resistance to antihypertensive treatment and long‐term risk: The Atherosclerosis Risk in Communities study

Blood pressure and mortality in patients with type 2 diabetes and a recent coronary event in the ELIXA trial

Angiotensin Receptor Neprilysin Inhibition: An Overlooked Frontier in the Treatment of Hypertension

Dissatisfaction with teeth in type 2 diabetes is associated with increased risk of cardiovascular disease

Sacubitril–valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction

Cardiac Structure and Function Across the Spectrum of Aldosteronism: the Atherosclerosis Risk in Communities Study

1089-P: Importance of Cardiorenal Complications for Prognosis in Persons with Type 1 Diabetes and Controls

Beta‐blockers, hypertension, and stroke outcomes

Importance of NT-proBNP and conventional risk factors for prediction of death in older adults with and without diabetes mellitus- A report from the Atherosclerosis Risk in Communities (ARIC) study

Effect of liraglutide on markers of insulin production in persons with type 2 diabetes treated with multiple daily insulin injections

The exaggerated blood pressure response to exercise in the sub‐acute phase after stroke is not affected by aerobic exercise

64-OR: Sustained Intensive Treatment and Long-Term Effects on A1C Reduction (SILVER Study) by CGM in Persons with T1D Treated with MDI

NT-proBNP versus routine clinical risk factors as a predictor of cardiovascular events or death in people with dysglycemia – A brief report from the ORIGIN trial

Predictors and correlates of systolic blood pressure reduction with liraglutide treatment in patients with type 2 diabetes

2-OR: Impact of N Terminal Pro B-Type Natriuretic Peptide and High Sensitivity Cardiac Troponin on the Prediction of Death and Cardiovascular Events in High-Risk Patients with Type 2 Diabetes

Angiotensin Receptor Neprilysin Inhibition

HIGHER PREVALENCE OF MASKED UNCONTROLLED HYPERTENSION WITH NEW EUROPEAN BLOOD PRESSURE TARGETS IN AN ELDERLY PRIMARY CARE POPULATION

Discordance between mean glucose and time in range in relation to HbA 1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials

Evaluation of Effects of Continuous Glucose Monitoring on Physical Activity Habits and Blood Lipid Levels in Persons With Type 1 Diabetes Managed With MDI: An Analysis Based on the GOLD Randomized Trial (GOLD 8)

Treatment Satisfaction and Well-Being With CGM in People With T1D: An Analysis Based on the GOLD Randomized Trial

Abstract 14482: Apparent Resistant Hypertension is a Marker of Risk: The Atherosclerosis Risk in Communities (ARIC) Study

1421-P: The Impact of Blood Pressure on Risk of Death Is Influenced by Prior Cardiovascular Disease in Patients with Type 2 Diabetes and a Recent Coronary Event

Suchergebnisse filtern